AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Dec 3, 2021
29875_dirs_2021-12-03_0b692506-01fc-4577-a94f-c0b64c26840c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-12-01
Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-01 | Common Stock (restricted) | F | 68 | $88.78 | Disposed | 16921 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17497.2554 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $102.26 | 2022-04-01 | Common Stock (6059) | 6059 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (7044) | 7044 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (9050) | 9050 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (7513) | 7513 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (24240) | 24240 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (17157) | 17157 | Direct |
| Stock Option | $74.30 | 2031-04-01 | Common Stock (12094) | 12094 | Direct |
Footnotes
F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
F2: Options became exercisable in four equal annual installments beginning on 4/1/2016.
F3: Options became exercisable in four equal annual installments beginning on 4/1/2017.
F4: Options became exercisable in four equal annual installments beginning on 4/3/2018.
F5: Options became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Options became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.